RecruitingNCT05880797
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
Sponsor
Stanford University
Enrollment
1,000 participants
Start Date
Jul 7, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to better understand the natural history of oropharyngeal carcinoma (OPC), with or without an association with the human papilloma virus (HPV). For this study, the investigators plan to collect blood from OPC patients prior to treatment and at six subsequent time points.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients diagnosed with oropharyngeal carcinoma or patients with cancer of the unknown primary that is HPV associated, or possibly deemed to be originating from the oropharynx.
Exclusion Criteria1
- Not willing to sign consent
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05880797
Related Trials
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
NCT069848617 locations
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
NCT054915127 locations
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
NCT051088701 location
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
NCT050759809 locations
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
NCT0549590610 locations